本刊特点：CSCD核心期刊（2023-2024）,高质量科技期刊（T2）,SCIE（2024版）, 科技核心期刊（2024自然科学）,目次收录（维普）,目次收录（知网）,第一批认定学术期刊,外文期刊,
期刊基本信息
出版周期：月刊 级别：核心期刊
主管部门：中国科学院
主办单位：中国科学院脑科学与智能技术卓越创新中心、中国神经科学学会
编辑部：《神经科学通报（英文版）》编辑部
中国国内刊号：CN31-1975/R
国际标准刊号：ISSN 1673-7067；EISSN1995-8218
邮发代号：4-608
价格：100元/期
知网复合影响因子：1.552
知网综合影响因子：1.185
杂志社联系方式
地址：上海市岳阳路319号8号楼612室《神经科学通报（英文版）》编辑部
邮编：200031
电话：021-64032273；64032563；64170853；64032696
官网微信公众号：神经科学通报英文版（NeuroscienceBulletin）
官网邮箱：nsb@ion.ac.cn
官方网站：http://www.neurosci.cn/
杂志征稿投稿要求
Neuroscience Bulletin considers manuscripts of the following types:
Original Article
Review
Insight
Method
Protocol
Letter to the Editor
Research Highlight
All other types of articles including Correspondence are also being considered upon enquiry. The article type should be specified in the author’s cover letter.
Please note that NB intends to publish high quality research articles as a major part of the journal. Short reports and articles of other formats are only considered if the research work provides a major scientific breakthrough. The number of these other articles is limited in every issue.
Original Article
An original article contains original research materials and presents compelling data on conceptual advances in any area of neuroscience. The total character count of all sections of the main text (including references and figure legends but excluding supplemental data) should not exceed 80,000, including spaces. Up to 8 figures and/or tables are allowed for the entire manuscript. The minimum requirement of a submitted research article is 5,000 words excluding the references and at least 6 display items (figures and tables).
The submitted manuscript should be a substantial novel research study in all aspects of neuroscience, organizing a complete story with complex mechanisms elucidated using multiple techniques or approaches. It should provide mechanistic insights into a particular aspect of neuroscience field. NB also welcomes clinical research investigating the pathogenesis or diagnostic markers of a disease. Please note that for clinical trials, an Informed Consent should be provided as supplemental material and stated in the main text. NB no long accepts clinical research that lack insightful mechanistic implications. References are limited to 100.
Review
Authoritative reviews contribute greatly to our journal and we are interested in comprehensive articles well written to describe the cutting-edge development in any field of neuroscience for a general audience. The authors are expected to cover controversies in the field and propose their own viewpoints in an unbiased and justifiable way. In particular, the scope of the review should not be dominated by the authors’ own work. Reviews are usually 5,000 to 8,000 words in length (including an abstract of no more than 150 words, excluding the reference and title) and 3-6 schematic illustrations are strongly encouraged. Reviews are often contributed by research pioneers in the field and solicited by the editors. The authors are encouraged to submit a letter of inquiry before the submission.
……
更多详情：
http://www.neurosci.cn/forauthors/instructionstoauthors/